Bemnifosbuvir clinical trials
Also written RO7496998.
How each study uses bemnifosbuvir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2021 (5)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 5 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses bemnifosbuvir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 17
- Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)CompletedPhase 1Atea Pharmaceuticals, Inc.NCT07272889Written as Bemnifosbuvir/Ruzasvir (BEM/RZR)
- A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVCompletedPhase 2Atea Pharmaceuticals, Inc.NCT05904470Written as Bemnifosbuvir
- SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19CompletedPhase 3Atea Pharmaceuticals, Inc.NCT05629962Written as Bemnifosbuvir (BEM)
- Study of AT-527 in Subjects With Normal and Impaired Renal FunctionCompletedPhase 1Atea Pharmaceuticals, Inc.NCT05618314Written as AT-527
- Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic FunctionCompletedPhase 1Atea Pharmaceuticals, Inc.NCT05724693Written as Bemnifosbuvir (BEM)
- Study of Bemnifosbuvir on Cardiac Repolarization in Healthy SubjectsCompletedPhase 1Atea Pharmaceuticals, Inc.NCT05905484Written as Bemnifosbuvir (BEM)
- The Study of Bemnifosbuvir in Healthy Japanese SubjectsCompletedPhase 1Atea Pharmaceuticals, Inc.NCT05905497Written as Bemnifosbuvir (BEM)
- Drug-drug Interaction Study of Ruzasvir and BemnifosbuvirCompletedPhase 1Atea Pharmaceuticals, Inc.NCT05731843Written as Cohort 1 BEM + Ruzasvir
- Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital SettingTerminatedPhase 2Atea Pharmaceuticals, Inc.NCT04396106Written as AT-527
- Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19CompletedPhase 2Hoffmann-La RocheNCT04709835Written as AT-527
- Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a MealCompletedPhase 1Atea Pharmaceuticals, Inc.NCT05256732Written as AT-527 fasted
- Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected SubjectsWithdrawnPhase 1/2Atea Pharmaceuticals, Inc.NCT04309734Written as AT-527
- Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)CompletedPhase 1Atea Pharmaceuticals, Inc.NCT05137626Written as AT-527 + digoxin
- Bronchopulmonary PK of AT-527 (R07496998)CompletedPhase 1Atea Pharmaceuticals, Inc.NCT04877769Written as AT-527
- Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)CompletedPhase 1Atea Pharmaceuticals, Inc.NCT05154123Written as Drug: AT-527 + rosuvastatin
- Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) InfectionCompletedPhase 2Atea Pharmaceuticals, Inc.NCT04019717Written as AT-527
- Study of AT-527 in Healthy and HCV-Infected SubjectsCompletedPhase 1Atea Pharmaceuticals, Inc.NCT03219957Written as AT-527
Codes
What other systems call bemnifosbuvir · ClinicalTrials.gg INT015538
- UNII (FDA) 7UM3SQL968BEMNIFOSBUVIROne source FDA
- NCI Thesaurus C182118BemnifosbuvirOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 7UM3SQL968 | BEMNIFOSBUVIR | One source FDA |
| NCI Thesaurus | C182118 | Bemnifosbuvir | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.